This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Bosulif — Description, Dosage, Side Effects | PillsCard
OTC
Bosulif
INN: bosutinib
Data updated: 2026-05-02
Available in:
🇨🇿🇩🇪🇬🇧🇫🇷🇵🇹🇷🇺🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Pfizer Europe MA EEIG
ATC Code
L01EA04
Source
EMA · EMEA/H/C/002373
EUEMA:by INNUSDailyMed:Bosutinib
L01EA04(WHO)
AU:S4(Prescription only)UK:POM(Prescription only)US:℞-onlyEU:Rx-only
4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
380843-75-4N
5328940
5710
DB06616Y
4486102Y
5018V4AEZ0
D03252
CHEBI:39112Y
ChEMBL288441Y
DTXSID10861568
Interactive image
Clc1c(OC)cc(c(Cl)c1)Nc4c(C#N)cnc3cc(OCCCN2CCN(CC2)C)c(OC)cc34
InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)YKey:UBPYILGKFZZVDX-UHFFFAOYSA-NY
Bosutinib, sold under the brand nameBosulif, is a small moleculeBCR-ABLandsrctyrosine kinase inhibitorused for the treatment ofchronic myelogenous leukemia.
Originally synthesized byWyeth, it is being developed byPfizer.
⚠️ Warnings
• Caution should be exercised in patients with history of liver or heart disease, who are taking other medications, any allergy, during pregnancy and breastfeeding.
• Monitor liver function regularly while taking this medication.